貨號(hào)	規(guī)格	價(jià)格	上海	北京	武漢	南京
S87543-5mg	≥98%	￥210.00 S87543-5mg ￥210.00 2-3天	0 貨期：2-3天	-	-	-
S87543-10mg	≥98%	￥380.00 S87543-10mg ￥380.00 2-3天	0 貨期：2-3天	-	-	-
S87543-50mg	≥98%	￥1100.00 S87543-50mg ￥1100.00 2-3天	0 貨期：2-3天	-	-	-
S87543-100mg	≥98%	￥1800.00 S87543-100mg ￥1800.00 2-3天	0 貨期：2-3天	-	-	-

產(chǎn)品介紹

PF-04217903 mesylate is a potent ATP-competitive c-Met kinase inhibitor with Ki of 4.8 nM for human c-Met. PF-04217903 mesylate shows more than 1,000-fold selectivity relative to 208 kinases. Antiangiogenic properties

產(chǎn)品描述：

靶點(diǎn)：

Ki: 4.8 nM (human c-Met);c-Met/HGFR

體外研究：

PF-04217903 mesylate (0.1-10000 nM; 48-72 hours) inhibits proliferation of c-Met–amplified human GTL-16 gastric carcinoma and H1993 NSCLC cells with IC50 values of 12 and 30 nM, respectively[1].PF-04217903 mesylate induces apoptosis of GTL-16 cells (IC50=31 nM) . PF-04217903 mesylate also inhibits HGF-mediated cell migration and Matrigel invasion in several c-Met–overexpressing tumor cell lines such as human NCI-H441 lung carcinoma and HT29 colon carcinoma with IC50 values comparable with those for inhibition of c-Met phosphorylation in these cell lines (IC50= 7-12.5 nM). PF-04217903 mesylate displays similar potency to inhibit the activity of c-Met-H1094R, c-Met-R988C, and c-Met-T1010I with IC50 of 3.1 nM, 6.4 nM, and 6.7 nM, respectively, but has no inhibitory activity against c-Met-Y1230C with IC50 of >10 μM. Cell Proliferation Assay Cell Line: GTL-16, H1993 cells Concentration: 0.1, 1, 10, 100, 1000, 10000 nM Incubation Time: 48-72 hours Result: Inhibited proliferation of c-Met–amplified human GTL-16 gastric carcinoma and H1993 NSCLC cells with IC50 values of 12 and 30 nM, respectively. Apoptosis Analysis Cell Line: GTL-16 cells Concentration: 1.5-3333 nM Incubation Time: 48 hours Result: Induced apoptosis of GTL-16 cells (IC50=31 nM).

體內(nèi)研究：

PF-04217903 mesylate (1-30 mg/kg; p.o.; daily for 16 days) shows dose-dependent tumor growth inhibition, which correlated with the inhibition in c-Met phosphorylation in these tumors . PF-04217903 mesylate (5-50 mg/kg, p.o.; once daily for 3 days) dose dependently inhibits c-Met, Gab-1, Erk1/2, and AKT phosphorylation and induced apoptosis (cleaved caspase-3) in U87MG xenograft tumors at all dose levels. PF-04217903 mesylate shows a significant dose-dependent reduction of human IL-8 levels in both the U87MG and GTL-16 models and decreases human VEGFA levels in the GTL-16 model. PF-04217903 mesylate strongly induces phospho-PDGFRβ levels in U87MG xenograft tumors. Animal Model: Female nu/nu mice GTL-16 xenograft model Dosage: 1, 3, 10, 30 mg/kg Administration: Oral; daily for 16 days Result: Showed dose-dependent tumor growth inhibition, and was correlated with the inhibition in c-Met phosphorylation in these tumors.

參考文獻(xiàn)：

1. Timofeevski SL, et al. Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors. Biochemistry, 2009, 48(23), 5339-5349. 2. Shojaei F, et al. HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res, 2010, 70(24), 10090-10100. 3. Krumbach R, et al. Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance. Eur J Cancer, 2011, 47(8), 1231-1243.

溶解性：

Soluble in DMSO

保存條件：

-20℃

配置溶液濃度參考：

	1mg	5mg	10mg
1 mM	2.135 ml	10.673 ml	21.345 ml
5 mM	0.427 ml	2.135 ml	4.269 ml
10 mM	0.213 ml	1.067 ml	2.135 ml
50 mM	0.043 ml	0.213 ml	0.427 ml

注意：

部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(COA)

輸入產(chǎn)品批號(hào)：

如何獲取質(zhì)檢證書(COA)?

請(qǐng)輸入貨號(hào)和一個(gè)與之匹配的批號(hào)。
例如:
批號(hào)：JS298415 貨號(hào)：S20001-25g
在貨品標(biāo)簽上如何找到貨號(hào)和批號(hào)?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

質(zhì)量

濃度

體積

分子摩爾量

計(jì)算重置

玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

PF-04217903 (methanesulfonate)